Immune signaling in rosacea

Rosacea is a common chronic skin disease affecting mostly people aged 40 and above, with currently no cure. When it affects the eyelids and periocular skin, it leads to dry eye and potentially corneal damage. Research performed over the last decade shed light into the potential mechanisms leading to skin hypersensitivity and provided promising avenues for development of novel, rational therapeutics aimed at reducing the skin inflammatory state. In this review, we discuss the current knowledge on the mechanisms of rosacea in general and of periocular skin-affecting disease in particular, identify key questions that remain to be answered in future research, and offer a disease model that can explain the key characteristics of this disease, with particular emphasis on a potential positive feedback loop that could explain both the acute and chronic features of rosacea.

Automated summary

Rosacea is a common chronic skin disease that predominantly affects people aged 40 and above, with no current cure. When it affects the eyelids and periocular skin, it can lead to dry eye and potential corneal damage. Research in the past decade has shed light on potential mechanisms leading to skin hypersensitivity and has provided promising avenues for development of novel therapeutics aimed at reducing skin inflammation.